InterCure Ltd. (TLV:INCR)
534.80
-14.10 (-2.57%)
Oct 5, 2025, 3:50 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 252.23 million as of October 3, 2025. Its market cap has decreased by -26.45% in one year.
Market Cap
252.23M
Enterprise Value
385.68M
Revenue
238.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
534.80
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 252.23M, an increase of 3,835.67%. That is a compound annual growth rate of 28.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 258.88M | -4.74% |
Dec 31, 2024 | 271.76M | 28.77% |
Dec 31, 2023 | 211.05M | -61.66% |
Dec 29, 2022 | 550.52M | -40.95% |
Dec 30, 2021 | 932.28M | 111.63% |
Dec 31, 2020 | 440.52M | 9.02% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 75.93B |
Danel (Adir Yeoshua) | 3.00B |
Kamada | 1.33B |
Bait Bakfar | 974.87M |
BrainsWay | 959.64M |
SofWave Medical | 943.38M |
Ilex Medical | 747.81M |
Novolog (Pharm-Up 1966) | 661.07M |